TDAG51 in vascular calcification associated with chronic renal disease

TDAG51在与慢性肾病相关的血管钙化中的作用

• 批准号: 210368
• 负责人: Austin Richard C
• 金额: $ 25.63万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-09-01 至 2013-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=210368&lang=en
• 关键词: Apoptosis; Cardiovascular Disease; End Stage Renal Disease; Smooth Muscle Cells; Tdag51; Vascular Calcification

Cardiovascular disease (CVD) is the major cause of death in patients suffering from chronic kidney disease (CKD). Over half of all deaths in patients with end-stage renal disease result from CVD, with mortality rates 10 to 30-fold greater than in the gene

心血管疾病（CVD）是慢性肾病（CKD）患者死亡的主要原因。在终末期肾病患者中，超过一半的死亡是由心血管疾病引起的，其死亡率是基因组的10至30倍。